Ascendis Pharma (ASND) Soars 10.4%: Is Further Upside Left in the Stock?

Group 1: Ascendis Pharma - Ascendis Pharma A/S (ASND) shares increased by 10.4% to close at $168.84, driven by notable trading volume and a 6.2$152.81, with a 2.5% return over the past month [3] - The consensus EPS estimate for Repligen has decreased by 6.6% to $0.35, but this still represents a 25% increase compared to the previous year [4] - Repligen also holds a Zacks Rank of 3 (Hold), similar to Ascendis Pharma [4]